Fadel Aljawaheri

Fadel Aljawaheri is an experienced bioprocess development scientist and consultant with a focus on downstream processing (DSP) and scale-up projects. Current roles include Scientist Bioprocess Development at Batavia Biosciences, Consultant at VectorY, and Scientist Bioprocess Development at Teva Pharmaceuticals. Previous positions encompass leadership in DSP development during COVID-19 vaccine commercial manufacturing at HALIX B.V., and extensive consulting and scientific roles across various organizations, including MICREOS and The Janssen Pharmaceutical Companies of Johnson & Johnson. Fadel's expertise spans technology transfer, production scale-up, and the development of innovative bioprocess strategies.